10q10k10q10k.net
CRYO CELL INTERNATIONAL INC

CRYO CELL INTERNATIONAL INCCCELEarnings & Financial Report

NYSE

Cryo-Cell International, Inc. is a cord blood bank. It was founded by Dan Richard in 1989. Cryo-Cell International is the first private cord blood bank to separate and store stem cells. Cryo-Cell is headquartered outside of Tampa, in Oldsmar, Florida. In January 1997, the Company's stock began trading on the NASDAQ Small Cap market under symbol CCEL.

NextMar 30, 2026

CCEL Q3 2025 Key Financial Metrics

Revenue

$7.8M

Gross Profit

$6.0M

Operating Profit

$1.9M

Net Profit

$749.4K

Gross Margin

77.0%

Operating Margin

24.3%

Net Margin

9.6%

YoY Growth

-3.0%

EPS

$0.09

Financial Flow

CRYO CELL INTERNATIONAL INC Q3 2025 Financial Summary

CRYO CELL INTERNATIONAL INC reported revenue of $7.8M for Q3 2025, with a net profit of $749.4K (9.6% margin). Cost of goods sold was $1.8M, operating expenses totaled $4.1M.

Key Financial Metrics

Total Revenue$7.8M
Net Profit$749.4K
Gross Margin77.0%
Operating Margin24.3%
Report PeriodQ3 2025

CRYO CELL INTERNATIONAL INC Annual Revenue by Year

CRYO CELL INTERNATIONAL INC annual revenue history includes year-by-year totals (for example, 2024 revenue was $32.0M).

YearAnnual Revenue
2024$32.0M
2023$31.3M
2022$30.3M

Income Statement

Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025
Revenue$7.9M$7.9M$8.0M$8.1M$8.0M$8.0M$7.9M$7.8M
YoY Growth1.5%0.4%3.5%2.5%1.9%1.5%-1.4%-3.0%

Balance Sheet

Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025
Assets$61.2M$61.7M$62.6M$62.9M$64.7M$64.4M$64.4M$63.2M
Liabilities$72.3M$72.0M$73.3M$72.5M$77.9M$79.0M$80.0M$78.0M
Equity$-11.0M$-10.3M$-10.7M$-9.6M$-13.2M$-14.7M$-15.6M$-14.8M

Cash Flow

Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025
Operating CF$3.3M$-356865$1.8M$2.4M$2.2M$954063$707014$2.5M